Stephen Liu: Mark Kris’ Perspective on the Treatment Algorithms for EGFR Mutant NSCLC for DCLung26
Mark Kris/MSKCC

Stephen Liu: Mark Kris’ Perspective on the Treatment Algorithms for EGFR Mutant NSCLC for DCLung26

Stephen Liu,  Chief of the Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared on X:

“Join us in Washington, DC on Saturday, October 10 for DCLung26 – a one-day, comprehensive, multidisciplinary, discussion-based lung cancer CME update! Dr. Mark Kris will give his perspective on the current treatment algorithms for EGFR mutant NSCLC!”

Learn More

Stephen Liu

Other articles featuring Mark Kris on OncoDaily.